StudyFinder
APOL1 Long-term Kidney Transplantation Outcomes Network
Status: Recruiting
This study is being done to improve outcomes after kidney donation and kidney transplantation. We will test kidney donors and kidney transplant recipients for apolipoprotein L1 gene (called APOL1) variants (or forms of the gene) and to see how these may affect them. Genes control the traits inherited from your family such as your eye color or blood type. Only a blood sample (and possibly urine) will be collected. Information routinely collected as part of surgery will also be used in the study. There will not be any changes to usual medical care.
Sex: Male or Female
Age Group: Not specified
Inclusion Criteria:
• living kidney donors with self-reported recent African ancestry (defined as African American, Afro-Caribbean, Hispanic black or African)
• people who have received a kidney transplant from an eligible living or deceased donor with recent African ancestry
• people who have received multi-organ transplants including a kidney plus an additional organ (i.e. liver, heart, lung, pancreas, etc.) or pediatric en bloc and dual kidney transplants
Conditions:
Kidney, Prostate & Urinary
Keywords:
Chronic, Kidney Disease, Kidney Diseases, Kidney Failure, Kidney Transplant
Study Contact: Katherine Wu - wuxx1320@umn.edu
Principal Investigator: Rasha El-Rifai
IRB Number: SITE00000625
See this study on ClinicalTrials.gov